Search
ChatPaper
AI Writing
analysis
Analysis
编组
Open Data
more
More
RankingsMust ReadingJournal&ConferenceAI TRAI HistoryMaster Reading TreeXiaomai's Star TalentsTrajectoryTalentNDI TrackerAI sign LanguageOpen
VIPCreated with Sketch.

Tu1391 ¿Is It Really Needed to Discontinue Antiplatelet Agents (APA) Prior to EUS-FNA Performance?: a Prospective Comparative Study

Enrique Vazquez-Sequeiros,Fernando Gonzalez-Panizo, Jose R. Foruny-Olcina, Victor Defarges-Pons, Carmen Gonzalez-Garcia, Juan Angel Gonzalez-Martin,Diego Juzgado,Daniel Boixeda-Miquel,Agustin Albillos

Gastrointestinal Endoscopy（2013）

Cited 1|Views10
No score
Abstract
Most recent clinical practice guidelines recommend no discontinuation of antiplatelet agents (APA) like aspirin (ASA) prior to EUS-FNA of solid masses. On the other hand, if the patient (PT) is taking thienopyridines (TNP), discontinuation of the drug is advised. Evidence supporting this type of practice is limited (ASA) or does not exist (TNP).
More
Translated text
Key words
antiplatelet agents,apa,eus-fna
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined